Back to search
FDAFDA · Food and drugs·Recall number D-0110-2023

Prostaglandin (E1) Injection Solution, 20 mcg/ml, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA 20166.

Published January 18, 2023 · Recall initiated: December 30, 2022

Summary

FDA records drug Class II recall D-0110-2023, published January 18, 2023 and initiated December 30, 2022. Recalling firm: Northern VA Compounders PLLC; Status: Terminated; Reported quantity: 4 vials; Lot: Lot#: 11212022@5, Exp 1/5/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Northern VA Compounders PLLC
Distributor
Nationwide in the USA
Lot
Lot#: 11212022@5, Exp 1/5/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Prostaglandin (E1) Injection Solution, 20 mcg/ml, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA 20166. recalled?

Yes. FDA published recall D-0110-2023 on January 18, 2023. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit